Does point of care troponin testing speed up care of cardiac patients in emergency?
Phase 3
Completed
- Conditions
- Possible Acute Coronary Syndrome in emergency patientsCardiovascular - Other cardiovascular diseasesCardiovascular - Coronary heart disease
- Registration Number
- ACTRN12607000475448
- Lead Sponsor
- Conrad Loten
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
All patients presenting to emergency with possible acute coronary syndrome
Exclusion Criteria
1.patients with acute elevation of the ess to tee segment of their electrocardiogram 2.patients arriving with known elevated troponin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduced Length of Stay in the emergency department[measured from time of arrival to patient departure from emergency Department];Reduced Length of Stay in the emergency department[measured from time of arrival to patient departure from emergency Department]
- Secondary Outcome Measures
Name Time Method The primary analysis will be intention to treat, however it is intended to perform a secondary efficacy analysis which may demonstrate that the machines save time if not always actually used. This is because there will not be mandatory use of the intervention and staff may choose not to use it.[measured immediately on discharge]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does point-of-care troponin testing in trial ACTRN12607000475448 compare to in-lab methods for ED cardiac patient care?
What molecular pathways link troponin I elevation to acute coronary syndrome in emergency patients?
Which cardiac biomarkers synergize with point-of-care troponin testing to optimize patient stratification in ACS?
What adverse events are associated with rapid troponin testing in ED settings and how are they mitigated?
How does point-of-care troponin testing compare with high-sensitivity assays in diagnosing myocardial injury in the ED?